611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Relieve Ear Pressure While FlyingBlack Children Missing Out on Eczema TreatmentNew Framework Guides Tx Decisions for Atopic DermatitisHealth Tip: Recognizing SepsisAround the World, Too Little Relief for PainNearly 4 in 10 U.S. Adults Now ObeseFDA Panel Supports Gene Therapy for Kids With Rare Eye Disease30-Day Mortality Lower With Female SurgeonsDirect Primary Care May Fill Niche for Uninsured3 Factors That Could Raise Your Risk of Bloodstream InfectionStroke Risk Factors Are RisingTwo Ebola Vaccines Spur Lasting Immune ResponseHormone Therapy May Be OK for Women With MigrainesMigraine MattersMedial Temporal Lobe Surgery Linked to Prevalence of TinnitusHigher Levels of Fungus ID'd in Patients With Crohn'sWhere There's Type 1 Diabetes, Celiac Disease May FollowAntibiotic Use Not Linked to Islet, Celiac Disease AutoimmunitySome U.S. Olympians Got West Nile in Brazil, But Not ZikaPenicillin Misconceptions May Raise Post-Op Infection RiskHate UTIs? One Simple Step Can Cut the RiskIDSA: Retail Meat May Be a Transmission Source for UTIsLonger Anesthesia Duration Tied to More Surgical ComplicationsFirst Test to Detect Zika in Blood Donations ApprovedHealth Tip: Learn Symptoms of Childhood SinusitisLimiting 'Cold Time' Could Make More Organs Available for TransplantHealth Literacy Linked to Length of Stay After Abdominal SurgeryZika Vaccine Works in Early Human TrialHealth Tip: Understanding Loud Noise and Hearing LossAllergy Relief Do's and Don'tsPatient Factors Differ for Surgical, All-Cause ReadmissionComing Soon: A Faster Test for Antibiotics Against UTIs?Antibody Injections in Pregnancy Might Shield Fetus From ZikaHealth Tip: Giving BloodMore U.S. Measles Cases From No Vaccine vs. Imported DiseaseHigh Epsom Salt Intake Can Lead to Severe Liver InjuryTattoo Pigment Hypersensitivity Can Mimic LymphomaObesity Linked to 13 Types of CancerBlood Thinners Can Come With Dangerous Side EffectsMeasles Making a Comeback in the United StatesAfter Deepwater Oil Cleanup in Gulf, Ill Effects PersistState Laws Can Promote Hepatitis C Virus ScreeningHow Much Alcohol Is Really OK?Girls' Sports-Related Concussions May Last Twice As LongSingle Mutation Made Zika Virus More VirulentVi-Tetanus Toxoid Conjugate Vaccine Can Prevent TyphoidDialysis Patients Often End Up Back in the HospitalRespiratory Disease Death Rates Have SoaredGenetic Tweaks in Mosquitoes Might Curb Malaria TransmissionImmunochromatography Testing Differentiates Dengue, Zika
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

FDA Approves Device to Help Curb Cluster Headaches

HealthDay News
by -- Robert Preidt
Updated: Apr 19th 2017

new article illustration

WEDNESDAY, April 19, 2017 (HealthDay News) -- Cluster headaches, though rare, are among the most severe forms of headache a person can face.

But there's new hope for at least some patients. The U.S. Food and Drug Administration said it has approved a hand-held device to treat these attacks.

The noninvasive device, called gammaCore, works to reduce cluster headache pain by transmitting mild electrical stimulation to the vagus nerve through the skin on the neck. This is a large nerve that runs from the brain to the colon.

One headache specialist said effective therapies are needed.

Cluster headaches "can be devastating to a person," said Dr. Noah Rosen.

"Although they are uncommon, affecting about 1 in 2,000, they are severe, disabling and poorly understood," said Rosen, who directs Northwell Health's Headache Center in Great Neck, N.Y.

While certain medications such as sumatriptan (Imitrex) are used to quell headaches, they don't always work for cluster headaches.

"Attacks that occur six or more times a day can't effectively be treated with sumatriptan safely, given the maximum daily dosage," Rosen noted.

The newly approved device might offer an alternative for at least some patients with cluster headache, however.

The gammaCore technology is made by the U.S.-based neuroscience and technology company electroCore. FDA approval of gammaCore was based on two clinical trials that found the device was more effective than placebo in reducing cluster headache pain.

One trial of 85 patients with episodic cluster headache found that it reduced pain in about a third of patients compared to about 10 percent of those on placebo.

A second trial of 27 patients found that "a significantly higher percentage of attacks were pain-free" for people using the device compared to those on placebo -- meaning that their pain had ceased by 15 minutes after headache.

According to a company news release, "gammaCore was found to be safe and well-tolerated," with most side effects being "mild and transient."

There were some caveats, however. The device should not be used by patients with an active implantable medical device, such as a pacemaker, hearing aid implant or any implanted electronic device; those diagnosed with narrowing of the arteries; those who have had surgery to cut the vagus nerve in the neck; people with clinically significant high or low blood pressure or certain irregular heart rhythms; and children or pregnant women.

It should also not be used by patients with a metallic device such as a stent, bone plate or bone screw implanted in or near the neck, or patients who are using another medical device at the same time or any portable electronic device (for example, a mobile phone).

For some cluster headache patients, gammaCore "offers a hope for a different treatment approach," Rosen said, and "may be another option for this needful community."

Dr. Sami Saba is a neurologist at Lenox Hill Hospital in New York City.

He explained that cluster headaches are thought to arise because of an abnormality in the body's autonomic nervous system. GammaCore may work because it stimulates the vagus nerve, which "also modulates the autonomic nervous system," Saba explained.

In that sense, it may be treating the origins of the painful headaches, "as opposed to merely treating the symptoms," he said.

Still, Saba pointed out that the device did not help the majority of the participants in the two studies.

GammaCore is currently available in Europe and some other parts of the world, and is expected to be available in the United States later this year, according to the news release.

More information

The Migraine Trust has more on cluster headache.